B. Meyer

Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies.

D. Benjamin, K. Gordon, H. V. Van Epps, 2017, Blood.

Cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer.

E. Saksela, B. Meyer, 1973, Journal of the National Cancer Institute.